Monday, Dec 18, 2017
engineered enzymes for better healthcare

Enzolve Technologies, a UCD spin-out company, has formally launched its first CE-marked diagnostic test, which screens for phenylketonuria (PKU) in newborn babies. Enzolve's PKU test, based on engineered enzyme technology, has several advantages over the tests currently available on the market...

Read full article on the web   Irish Medical News May 15, 2009  or in pdf format   pdf_button

 

  Back to the News page 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...